T Cell transformation by herpesvirus saimiri requires STAT5 pathways

被引：0
|
作者：
D Lengenfelder
B Vogel
ED Mazumder
B Scholz
E Heck
M Schmidt
I Müller-Fleckenstein
B Fleckenstein
B Biesinger
A Ensser
机构：
[1] Friedrich-Alexander Universität Erlangen-Nürnberg,Institut für Klinische und Molekulare Virologie
来源：
Cell Communication and Signaling | / 7卷 / Suppl 1期
关键词：
STAT5 Pathway; STAT5 Signalling Pathway; Y127F Mutant; Growth Factor Requirement; Viral Transformation;
D O I：
10.1186/1478-811X-7-S1-A80
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] STAT5 induces miR-21 expression in cutaneous T cell lymphoma
    Lindahl, Lise M.
    Fredholm, Simon
    Joseph, Claudine
    Nielsen, Boye Schnack
    Jonson, Lars
    Willerslev-Olsen, Andreas
    Gluud, Maria
    Bluemel, Edda
    Petersen, David L.
    Sibbesen, Nina
    Hu, Tengpeng
    Nastasi, Claudia
    Krejsgaard, Thorbjorn
    Jaehger, Ditte
    Persson, Jenny L.
    Mongan, Nigel
    Wasik, Mariusz A.
    Litvinov, Ivan V.
    Sasseville, Denis
    Koralov, Sergei B.
    Bonefeld, Charlotte M.
    Geisler, Carsten
    Woetmann, Anders
    Ralfkiaer, Elisabeth
    Iversen, Lars
    Odum, Niels
    ONCOTARGET, 2016, 7 (29) : 45730 - 45744
  • [32] Dissecting the role of STAT3 and STAT5 in antitumor T cells
    Zhang, Haosong
    Kagoya, Yuki
    CANCER SCIENCE, 2025, 116 : 511 - 511
  • [33] DOCK8 Associates with STAT5 and Promotes Regulatory T Cell Function
    Janssen, Erin
    Tohme, Mira
    Ullas, Sumana
    Geha, Raif
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [34] Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma
    Kelly, JA
    Spolski, R
    Kovanen, PE
    Suzuki, T
    Bollenbacher, J
    Pise-Masison, CA
    Radonovich, MF
    Lee, S
    Jenkins, NA
    Copeland, NG
    Morse, HC
    Leonard, WJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (01): : 79 - 89
  • [35] STAT5 is a therapeutically targetable vulnerability in leukemic cutaneous T-cell lymphoma
    Dey, S.
    Sorger, H.
    Vieyra-Garcia, P.
    Araujo, E. D.
    Graf, R.
    Spiegl, B.
    Schlederer, M.
    Graier, T.
    Perchthaler, I.
    Fink-Puches, R.
    Cerroni, L.
    Surbek, M.
    Pirker, C.
    Berger, W.
    Orlova, A.
    Herling, M.
    Merkel, O.
    Neubauer, H. A.
    Gunning, P. T.
    Heitzer, E.
    Kenner, L.
    Moriggl, R.
    Wolf, P.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 (03) : E100 - E101
  • [36] Stat5 Regulates Mast Cell Activation by IgE
    Barnstein, Brian
    Tarleton, Christy
    Wilson, Bridget
    Ryan, John J.
    FASEB JOURNAL, 2008, 22
  • [37] Stat5 expression is critical to mast cell development
    Barnstein, B
    Ryan, J
    FASEB JOURNAL, 2004, 18 (05): : A789 - A789
  • [38] m6A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways
    Li, Hua-Bing
    Tong, Jiyu
    Zhu, Shu
    Batista, Pedro J.
    Duffy, Erin E.
    Zhao, Jun
    Bailis, Will
    Cao, Guangchao
    Kroehling, Lina
    Chen, Yuanyuan
    Wang, Geng
    Broughton, James P.
    Chen, Y. Grace
    Kluger, Yuval
    Simon, Matthew D.
    Chang, Howard Y.
    Yin, Zhinan
    Flavell, Richard A.
    NATURE, 2017, 548 (7667) : 338 - +
  • [39] m6A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways
    Hua-Bing Li
    Jiyu Tong
    Shu Zhu
    Pedro J. Batista
    Erin E. Duffy
    Jun Zhao
    Will Bailis
    Guangchao Cao
    Lina Kroehling
    Yuanyuan Chen
    Geng Wang
    James P. Broughton
    Y. Grace Chen
    Yuval Kluger
    Matthew D. Simon
    Howard Y. Chang
    Zhinan Yin
    Richard A. Flavell
    Nature, 2017, 548 : 338 - 342
  • [40] Stat5: an essential regulator of mast cell biology
    Shelburne, CP
    McCoy, ME
    Piekorz, R
    Sexl, VV
    Gillespie, SR
    Bailey, DP
    Gharse, A
    Mirmonsef, P
    Mann, MN
    Kashyap, M
    Wright, HV
    Chong, HJ
    Bouton, LA
    Ramirez, CD
    Lantz, CS
    Ryan, JJ
    MOLECULAR IMMUNOLOGY, 2002, 38 (16-18) : 1187 - 1191
12345